Richard /Ca/ Murray Jounce Therapeutics, Inc. (JNCE) insider trading activity

Richard /Ca/ Murray is Director of Jounce Therapeutics, Inc.. Currently has a direct ownership of 1 shares of JNCE, which is worth approximately $0. The most recent transaction as insider was on May 03, 2023, when has been sold 188,778 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1

0% 3M change

0% 12M change

Total Value Held $0

RICHARD /CA/ MURRAY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 03 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	188,778 Reduced 100.0%	1 Common Stock
Apr 04 2023	SELL Open market or private sale	$72,571 $1.85 p/Share	39,228 Reduced 17.2%	188,779 Common Stock
Jan 10 2023	SELL Open market or private sale	$27,864 $1.12 p/Share	24,879 Reduced 9.84%	228,007 Common Stock
Jan 09 2023	SELL Open market or private sale	$22,210 $1.1 p/Share	20,191 Reduced 7.39%	252,886 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	87,500 Added 24.27%	273,077 Common Stock
Jan 10 2022	SELL Open market or private sale	$159,095 $6.65 p/Share	23,924 Reduced 11.42%	185,577 Common Stock
Jan 07 2022	SELL Open market or private sale	$97,601 $7.3 p/Share	13,370 Reduced 6.0%	209,501 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	7,500 Added 3.26%	222,871 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	75,000 Added 25.83%	215,371 Common Stock
Jan 21 2021	SELL Open market or private sale	$404,227 $12.06 p/Share	33,518 Reduced 19.28%	140,371 Common Stock
Jan 21 2021	BUY Exercise of conversion of derivative security	$16,089 $0.48 p/Share	33,518 Added 16.16%	173,889 Common Stock
Jan 20 2021	SELL Open market or private sale	$198,443 $12.04 p/Share	16,482 Reduced 10.51%	140,371 Common Stock
Jan 20 2021	BUY Exercise of conversion of derivative security	$7,911 $0.48 p/Share	16,482 Added 9.51%	156,853 Common Stock
Jan 19 2021	SELL Open market or private sale	$383,600 $9.59 p/Share	40,000 Reduced 22.18%	140,371 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$19,200 $0.48 p/Share	40,000 Added 18.15%	180,371 Common Stock
Jan 15 2021	SELL Open market or private sale	$256,200 $8.54 p/Share	30,000 Reduced 17.61%	140,371 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$14,400 $0.48 p/Share	30,000 Added 14.97%	170,371 Common Stock
Jan 08 2021	SELL Open market or private sale	$82,712 $7.0 p/Share	11,816 Reduced 7.76%	140,371 Common Stock
Jan 07 2021	SELL Open market or private sale	$68,837 $6.76 p/Share	10,183 Reduced 6.27%	152,187 Common Stock

R/M

Richard /Ca/ Murray

Director

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNCE shares.

Notify only if

Value

Insider Trading

Get notified when an Jounce Therapeutics, Inc. insider buys or sells JNCE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jounce Therapeutics, Inc.

Track Activities on JNCE

Account